These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. [Choice of early and escalation treatment options for multiple sclerosis]. Linker RA; Kieseier BC Nervenarzt; 2008 Oct; 79(10):1123-4,1126-8,1130-2 passim. PubMed ID: 18806985 [TBL] [Abstract][Full Text] [Related]
30. Management of multiple sclerosis: current trials and future options. Noseworthy JH Curr Opin Neurol; 2003 Jun; 16(3):289-97. PubMed ID: 12858064 [TBL] [Abstract][Full Text] [Related]
31. Immunomodulatory treatment in multiple sclerosis: experience at a Brazilian center with 390 patients. Tilbery CP; Mendes MF; Oliveira BE; Thomaz RB; Kelian GR Arq Neuropsiquiatr; 2006 Mar; 64(1):51-4. PubMed ID: 16622553 [TBL] [Abstract][Full Text] [Related]
32. The significance of neutralizing antibodies in patients with multiple sclerosis treated with interferon beta. Rice G Arch Neurol; 2001 Aug; 58(8):1297-8. PubMed ID: 11493173 [No Abstract] [Full Text] [Related]
33. Rebif offers another option for treating multiple sclerosis. Ryan M J Am Pharm Assoc (Wash); 2002; 42(6):889-91. PubMed ID: 12482017 [No Abstract] [Full Text] [Related]
34. A comparison of the benefits of mitoxantrone and other recent therapeutic approaches in multiple sclerosis. Gonsette RE Expert Opin Pharmacother; 2004 Apr; 5(4):747-65. PubMed ID: 15102561 [TBL] [Abstract][Full Text] [Related]
37. Neutralizing antibodies and the efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis. Petkau J; White R Mult Scler; 1997 Dec; 3(6):402. PubMed ID: 9493643 [No Abstract] [Full Text] [Related]
38. Balancing the benefits and risks of disease-modifying therapy in patients with multiple sclerosis. Sørensen PS J Neurol Sci; 2011 Dec; 311 Suppl 1():S29-34. PubMed ID: 22206763 [TBL] [Abstract][Full Text] [Related]
39. [Rationale for an early treatment of multiple sclerosis]. Comi G; Martino G Rev Neurol; 2000 Jun 16-30; 30(12):1265-8. PubMed ID: 10935262 [TBL] [Abstract][Full Text] [Related]